<DOC>
	<DOCNO>NCT00757848</DOCNO>
	<brief_summary>The purpose study investigate treatment AZD9668 28 day effective treat Cystic Fibrosis ( CF ) compare placebo ( substance action ) .</brief_summary>
	<brief_title>A Phase II , Placebo-controlled Study Assess Efficacy 28 Day Oral AZD9668 Patients With Cystic Fibrosis</brief_title>
	<detailed_description />
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<criteria>Male postmenopausal surgically sterile female patient Have clinical diagnosis Cystic Fibrosis lung function test great equal 40 % normal Have normal renal function Lung transplant patient Significant liver disease Any nonCFrelated lung disease may interfere study assessment</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>cystic fibrosis</keyword>
</DOC>